Sanofi
corporate_fare Company Profile
Sanofi (NASDAQ:SNY) is a publicly traded company in the Life Sciences sector. Wiseek monitors SNY SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Sanofi's Rilzabrutinib Receives FDA Breakthrough Therapy and Japan Orphan Drug Designations for wAIHA
- Sanofi Appoints Belén Garijo as New CEO, Paul Hudson to Depart
- Sanofi Completes Acquisition of Dynavax, Bolstering Adult Immunization Portfolio
- Sanofi Successfully Completes Tender Offer for Dynavax, Initiates Short-Form Merger
- Sanofi Advances Pipeline with EU Rezurock Nod, Positive Gaucher Data, and Initiates €1B Share Buyback
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
$7.85B
Diluted EPS
$6.37
Op. Cash Flow
$10.75B
Free Cash Flow
$7.21B
Gross Profit
$33.67B
Operating Income
$6.34B
Cash & Equivalents
$877M
Total Debt
$14.25B
Debt / Equity
0.20×
Shares Outstanding
1.22B sh
Source: 20-F · filed 2026-02-17 · accession 0001628280-26-008403
Insider Transactions
SNY files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.
show_chartPrice Chart
Loading chart...
feed SNY - Filings & News (Page 2)
SNY
Feb 17, 2026, 9:33 AM EST
Price at Filing:
$46.29
Real-time Price:
$44.30
Change:
-$1.98 (-4%)
Market Cap:
$106.911B
SNY
Feb 12, 2026, 9:17 AM EST
Price at Filing:
$46.91
Real-time Price:
$44.30
Change:
-$2.61 (-6%)
Market Cap:
$106.911B
SNY
Feb 10, 2026, 9:18 AM EST
Price at Filing:
$48.66
Real-time Price:
$44.30
Change:
-$4.36 (-9%)
Market Cap:
$106.911B
SNY
Feb 10, 2026, 6:06 AM EST
Price at Filing:
$48.65
Real-time Price:
$44.30
Change:
-$4.35 (-9%)
Market Cap:
$106.911B
SNY
Feb 06, 2026, 10:09 AM EST
Price at Filing:
$47.37
Real-time Price:
$44.30
Change:
-$3.07 (-6%)
Market Cap:
$106.911B
SNY
Jan 30, 2026, 7:55 AM EST
Price at Filing:
$46.58
Real-time Price:
$44.30
Change:
-$2.28 (-5%)
Market Cap:
$106.911B
SNY
Jan 29, 2026, 8:56 AM EST
Price at Filing:
$46.52
Real-time Price:
$44.30
Change:
-$2.22 (-5%)
Market Cap:
$106.911B
SNY
Jan 28, 2026, 6:37 AM EST
Price at Filing:
$46.64
Real-time Price:
$44.30
Change:
-$2.34 (-5%)
Market Cap:
$106.911B
SNY
Jan 23, 2026, 9:58 AM EST
Amlitelimab Phase 3 Studies Show Mixed Results in Atopic Dermatitis, Sanofi Plans Global Submissions
Price at Filing:
$46.42
Real-time Price:
$44.30
Change:
-$2.12 (-5%)
Market Cap:
$106.911B
SNY
Jan 16, 2026, 6:02 AM EST
Price at Filing:
$45.52
Real-time Price:
$44.30
Change:
-$1.22 (-3%)
Market Cap:
$106.911B
SNY
Jan 12, 2026, 6:11 AM EST
Price at Filing:
$49.43
Real-time Price:
$44.30
Change:
-$5.13 (-10%)
Market Cap:
$106.911B
SNY
Jan 09, 2026, 6:09 AM EST
Price at Filing:
$48.53
Real-time Price:
$44.30
Change:
-$4.23 (-9%)
Market Cap:
$106.911B